MX2012010084A - Compuestos utiles para tratar transtornos neurodegenerativos. - Google Patents
Compuestos utiles para tratar transtornos neurodegenerativos.Info
- Publication number
- MX2012010084A MX2012010084A MX2012010084A MX2012010084A MX2012010084A MX 2012010084 A MX2012010084 A MX 2012010084A MX 2012010084 A MX2012010084 A MX 2012010084A MX 2012010084 A MX2012010084 A MX 2012010084A MX 2012010084 A MX2012010084 A MX 2012010084A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds useful
- neurodegenerative disorders
- treating neurodegenerative
- treating
- lessening
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
- C07G3/00—Glycosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0057—Nitrogen and oxygen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
La invención se refiere a compuestos que resulta de utilidad para tratar o atenuar la gravedad de un trastorno neurodegenerativo. La presente invención también se refiere s un método para tratar o atenuar la gravedad de los trastornos, donde el método comprende administrarle aun paciente un compuesto de la presente invención o una composición de éste. El método resulta de utilidad para tratar o atenuar la gravedad de, por ejemplo, el mal de Alzheirme.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31015210P | 2010-03-03 | 2010-03-03 | |
| PCT/US2011/027084 WO2011109657A1 (en) | 2010-03-03 | 2011-03-03 | Compounds useful for treating neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012010084A true MX2012010084A (es) | 2013-01-18 |
Family
ID=44542588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012010084A MX2012010084A (es) | 2010-03-03 | 2011-03-03 | Compuestos utiles para tratar transtornos neurodegenerativos. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20110251379A1 (es) |
| EP (1) | EP2542085A4 (es) |
| JP (1) | JP2013521307A (es) |
| KR (1) | KR20120136378A (es) |
| CN (1) | CN102939011A (es) |
| AR (1) | AR080455A1 (es) |
| AU (1) | AU2011223542A1 (es) |
| BR (1) | BR112012022224A2 (es) |
| CA (1) | CA2790060A1 (es) |
| IL (1) | IL221415A0 (es) |
| MX (1) | MX2012010084A (es) |
| RU (1) | RU2012135118A (es) |
| TW (1) | TW201134476A (es) |
| WO (1) | WO2011109657A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201317257A (zh) * | 2011-09-07 | 2013-05-01 | Satori Pharmaceuticals Inc | 用於治療神經退化性病症之化合物 |
| US20130060019A1 (en) * | 2011-09-07 | 2013-03-07 | Satori Pharmaceuticals, Inc. | Compounds for Use in Treating Neurodegenerative Disorders, Synthesis Thereof, and Intermediates Thereto |
| PT3461834T (pt) * | 2013-03-13 | 2021-09-10 | Sage Therapeutics Inc | Esteroides neuroativos |
| KR101472916B1 (ko) * | 2013-06-27 | 2014-12-16 | 한국과학기술연구원 | 모르폴린 또는 피페라진 화합물, 및 도네페질을 포함하는 인지 장애 관련 질병의 예방 또는 치료용 약학적 조성물 |
| CN108426999B (zh) * | 2017-02-15 | 2020-10-23 | 江苏美正生物科技有限公司 | 一种金刚烷胺残留的快速检测试剂盒及其制备方法和应用 |
| DE102017008073A1 (de) * | 2017-08-28 | 2019-02-28 | Henkel Ag & Co. Kgaa | Neue anionische Tenside und Wasch- und Reinigungsmittel, welche diese enthalten |
| CN112457362B (zh) * | 2019-09-06 | 2023-09-19 | 上海青东生物科技有限公司 | 一种卤代四环三萜衍生物及其制备与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9600229D0 (sv) * | 1996-01-23 | 1996-01-23 | Pharmacia Ab | Novel potentiating agents |
| US20070149491A1 (en) * | 2005-05-17 | 2007-06-28 | Findeis Mark A | Compounds useful for treating neurodegenerative disorders |
| BRPI0611528A2 (pt) * | 2005-05-17 | 2010-11-23 | Satori Pharmaceuticals Inc | compostos úteis para tratamento de distúrbios neurodegenerativos |
| EP2073638B1 (en) * | 2006-11-20 | 2013-05-15 | Satori Pharmaceuticals, Inc. | Synthesis of compounds useful as modulators of amyloid-beta production |
| CN101339167B (zh) * | 2008-08-27 | 2011-12-14 | 中国药科大学 | 基于靶蛋白亲和选择的活性成分高通量筛选方法 |
| EP2438921A1 (en) * | 2010-10-11 | 2012-04-11 | Universität Innsbruck | 23-O-Acetylshengmanol-3-O-beta-D-xylopyranoside and its medical use |
-
2011
- 2011-03-03 BR BR112012022224A patent/BR112012022224A2/pt not_active IP Right Cessation
- 2011-03-03 AR ARP110100671A patent/AR080455A1/es unknown
- 2011-03-03 MX MX2012010084A patent/MX2012010084A/es not_active Application Discontinuation
- 2011-03-03 US US13/040,166 patent/US20110251379A1/en not_active Abandoned
- 2011-03-03 RU RU2012135118/04A patent/RU2012135118A/ru not_active Application Discontinuation
- 2011-03-03 TW TW100107238A patent/TW201134476A/zh unknown
- 2011-03-03 WO PCT/US2011/027084 patent/WO2011109657A1/en active Application Filing
- 2011-03-03 AU AU2011223542A patent/AU2011223542A1/en not_active Abandoned
- 2011-03-03 KR KR1020127025648A patent/KR20120136378A/ko not_active Application Discontinuation
- 2011-03-03 EP EP11751383.8A patent/EP2542085A4/en not_active Withdrawn
- 2011-03-03 CN CN2011800224223A patent/CN102939011A/zh active Pending
- 2011-03-03 JP JP2012556249A patent/JP2013521307A/ja not_active Withdrawn
- 2011-03-03 CA CA2790060A patent/CA2790060A1/en not_active Abandoned
-
2012
- 2012-08-12 IL IL221415A patent/IL221415A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013521307A (ja) | 2013-06-10 |
| EP2542085A1 (en) | 2013-01-09 |
| AR080455A1 (es) | 2012-04-11 |
| RU2012135118A (ru) | 2014-04-10 |
| US20110251379A1 (en) | 2011-10-13 |
| EP2542085A4 (en) | 2013-12-04 |
| TW201134476A (en) | 2011-10-16 |
| IL221415A0 (en) | 2012-10-31 |
| KR20120136378A (ko) | 2012-12-18 |
| CA2790060A1 (en) | 2011-09-09 |
| AU2011223542A1 (en) | 2012-09-13 |
| CN102939011A (zh) | 2013-02-20 |
| WO2011109657A1 (en) | 2011-09-09 |
| BR112012022224A2 (pt) | 2016-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2542085A4 (en) | COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISORDER | |
| WO2008130449A3 (en) | Modulators of amyloid-beta production | |
| MX2009005351A (es) | Compuestos utiles para tratar trastornos neurodegenerativos. | |
| IN2014CN04907A (es) | ||
| MX2015007479A (es) | Tiazolidindionas ahorradoras de receptores activados proliferadores de peroxisoma (ppar) y combinaciones para el tratamiento de enfermedades neurodegenerativas. | |
| TN2015000018A1 (en) | 5-ht3 receptor antagonists | |
| WO2012040641A3 (en) | Compounds for treating neurodegenerative diseases | |
| UA113051C2 (xx) | Гетероциклічні похідні та їх застосування у лікуванні неврологічних розладів | |
| UA106692C2 (uk) | ІМІДАЗО[5,1-f][1,2,4]ТРИАЗИНИ ДЛЯ ЛІКУВАННЯ НЕВРОЛОГІЧНИХ РОЗЛАДІВ | |
| MX2020012825A (es) | Compuestos multiciclicos y metodos de uso de los mismos. | |
| NZ603789A (en) | Heteroaryl compounds and methods of use thereof | |
| MX357761B (es) | Métodos para tratar la enfermedad de alzheimer, enfermedad de huntington, autismo u otros trastornos. | |
| WO2013033037A3 (en) | Novel antiprion compounds | |
| EA200971050A1 (ru) | Способы лечения и предупреждения нейродегенеративных заболеваний и нарушений | |
| TN2014000112A1 (en) | Ep1 receptor ligands | |
| WO2013040227A3 (en) | Therapeutic compounds | |
| WO2013014665A8 (en) | Intermediate compounds and process for the preparation of lurasidone and salts thereof | |
| MX2013008699A (es) | Compuestos para reducir la produccion de beta-amiloide. | |
| EA201001586A1 (ru) | Соединения и композиции в качестве ингибиторов itpkb | |
| WO2008136863A3 (en) | Synthesis of compounds useful as modulators of amyloid-beta production | |
| MX2014014066A (es) | Compuestos de cromano. | |
| WO2015077535A3 (en) | Novel methods for treating neurodegenerative diseases | |
| WO2012103282A3 (en) | Methods and compositions for treating alzheimer's disease | |
| TN2012000191A1 (en) | Quinuclidine compounds as alpha-7nicotinic acetylcholine receptor ligands | |
| IN2014DN09826A (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |